Associate Director, HEOR, Hematology, Europe and New Markets

ph3About BeOne Medicines /h3 pBeOne Medicines is a global oncology company focused on discovering and developing innovative medicines to improve treatment outcomes and access for patients with cancer worldwide. With a growing portfolio and pipeline, BeOne operates in a dynamic, science-driven and highly cross-functional environment. /p h3About BeOne Medicines /h3 pBeOne Medicines is a global oncology company focused on discovering and developing innovative medicines to improve treatment outcomes and access for patients with cancer worldwide. With a growing portfolio and pipeline, BeOne operates in a dynamic, science-driven and highly cross-functional environment. /p pThe Europe and New Markets HEOR team works across the hematology portfolio to generate evidence supporting the value of our medicines, European and country-level HTA and reimbursement and broader evidence needs throughout the product lifecycle. /p h3Who We Are Looking For /h3 pWe are looking for an experienced HEOR professional who can quickly integrate into the team and provide hands‑on support across a range of ongoing and emerging priorities. Given the short term nature of the assignment, the successful candidate should be comfortable rolling up their sleeves, taking ownership of projects and moving work forward with a high degree of independence. /p pThe role requires someone who combines strong technical HEOR capabilities with a pragmatic and solution‑oriented mindset. Excellent communication and stakeholder‑management skills are important, as the individual will work with multiple teams across the organization, including HEOR, Market Access, Medical Affairs, Clinical Development, Biostatistics, Regulatory Affairs and Global functions, as well as external vendors and research partners. /p pThe ideal candidate is comfortable working in a fast‑paced environment where priorities may evolve, can manage several workstreams simultaneously, and knows when to work independently versus when to bring the right stakeholders together to make decisions and resolve issues. /p h3This role is part‑time position /h3 h3Responsibilities /h3 ul liSupport and manage HEOR activities across hematology assets in Europe and New Markets, ensuring high‑quality and timely delivery of evidence to support HTA, reimbursement and broader evidence needs. /li liWork cross‑functionally with Market Access, Medical Affairs, Clinical Development, Biostatistics and Global teams to identify evidence gaps and prioritize HEOR activities according to regional and country needs. /li liSupport the development and execution of HEOR evidence‑generation activities, including comparative effectiveness research, real‑world evidence, economic analyses and other projects according to business needs. /li liSupport development and review of study protocols, analysis plans, reports, publications and other HEOR deliverables, ensuring methodological quality and appropriate interpretation of results. /li liContribute to the European HTA and EU Joint Clinical Assessment (JCA) evidence strategy, including preparation and execution of evidence‑generation activities required to support upcoming assessments. /li liSupport JCA PICO strategy and planning, including assessment of anticipated populations, subgroups, comparators and outcomes, identification of evidence gaps, and evaluation of the feasibility of addressing different PICOs. /li liLead or support comparative evidence generation for JCA and other HTA needs. /li liWork with internal teams and external vendors to evaluate available clinical trial, external and real‑world data and determine appropriate approaches to address identified evidence gaps. /li liManage external HEOR vendors and projects, including scope development, methodological review, timelines, deliverables and quality control.len /liliSupport interpretation and communication of HEOR evidence, including methodological assumptions, uncertainty, limitations and implications for HTA and evidence strategy. /li liProvide additional HEOR support across the hematology portfolio as priorities evolve during the contract period. /li /ul h3Requirements /h3 ul liMaster's degree or PhD in Health Economics, Outcomes Research, Epidemiology, Public Health, Statistics or a related discipline. /li liAt least 5 years of relevant experience in HEOR, HTA, RWE or comparative effectiveness research, preferably within the pharmaceutical industry or consulting. /li liGood understanding of European HTA and evidence requirements; knowledge or experience with the EU HTA Regulation and JCA would be a strong asset. /li liExperience with comparative effectiveness methods such as ITC/NMA and population‑adjusted approaches (e.g. MAIC/STC) would be highly desirable. /li liExperience designing, managing and critically reviewing HEOR studies and working with external research vendors. /li liKnowledge or experience in hematology/oncology would be an asset. /li liStrong analytical and critical‑thinking skills, with the ability to translate evidence gaps into practical research activities. /li liAbility to work effectively in a cross‑functional matrix environment and manage multiple projects and changing priorities. /li liExcellent written and verbal communication skills in English. /li liHighly organized, proactive and able to work independently in a fast‑paced environment. /li /ul /p #J-18808-Ljbffr